Prevalence Survey of
Healthcare Associated Infections (HAIs) and Antimicrobial Use in
U.S. Acute Care Hospitals
Extension without change of a currently approved collection
No
Regular
12/27/2021
Requested
Previously Approved
36 Months From Approved
10/31/2022
6,400
6,400
1,860
1,860
65,770
65,770
Preventing healthcare-associated
infections (HAIs) and improving antimicrobial use (AU) are CDC and
national priorities. An extension of the prevalence survey’s
existing OMB approval is sought to allow a repeat HAI and AU
Prevalence Survey to be performed in 2020. A repeat survey will
allow assessment of changes in HAI and AU prevalence, pathogen
distribution, and quality of antimicrobial prescribing. These data
will also allow CDC and its partners to continue to monitor HAI and
AU trends, to measure progress in meeting national targets, and to
further refine prevention strategies.
US Code:
42
USC 241 Name of Law: Public Health Service Act
PL:
Pub.L. 111 - 5 1 Name of Law: American Recovery and
Reinvestment Act of 2009
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.